500 related articles for article (PubMed ID: 22133721)
1. The PDL1-PD1 axis converts human TH1 cells into regulatory T cells.
Amarnath S; Mangus CW; Wang JC; Wei F; He A; Kapoor V; Foley JE; Massey PR; Felizardo TC; Riley JL; Levine BL; June CH; Medin JA; Fowler DH
Sci Transl Med; 2011 Nov; 3(111):111ra120. PubMed ID: 22133721
[TBL] [Abstract][Full Text] [Related]
2. PD-1 Inhibitory Receptor Downregulates Asparaginyl Endopeptidase and Maintains Foxp3 Transcription Factor Stability in Induced Regulatory T Cells.
Stathopoulou C; Gangaplara A; Mallett G; Flomerfelt FA; Liniany LP; Knight D; Samsel LA; Berlinguer-Palmini R; Yim JJ; Felizardo TC; Eckhaus MA; Edgington-Mitchell L; Martinez-Fabregas J; Zhu J; Fowler DH; van Kasteren SI; Laurence A; Bogyo M; Watts C; Shevach EM; Amarnath S
Immunity; 2018 Aug; 49(2):247-263.e7. PubMed ID: 30054205
[TBL] [Abstract][Full Text] [Related]
3. Programmed Cell Death Protein 1-PDL1 Interaction Prevents Heart Damage in Chronic
Fonseca R; Salgado RM; Borges da Silva H; do Nascimento RS; D'Império-Lima MR; Alvarez JM
Front Immunol; 2018; 9():997. PubMed ID: 29867974
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin generates anti-apoptotic human Th1/Tc1 cells via autophagy for induction of xenogeneic GVHD.
Amarnath S; Flomerfelt FA; Costanzo CM; Foley JE; Mariotti J; Konecki DM; Gangopadhyay A; Eckhaus M; Wong S; Levine BL; June CH; Fowler DH
Autophagy; 2010 May; 6(4):523-41. PubMed ID: 20404486
[TBL] [Abstract][Full Text] [Related]
5. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality.
Saha A; O'Connor RS; Thangavelu G; Lovitch SB; Dandamudi DB; Wilson CB; Vincent BG; Tkachev V; Pawlicki JM; Furlan SN; Kean LS; Aoyama K; Taylor PA; Panoskaltsis-Mortari A; Foncea R; Ranganathan P; Devine SM; Burrill JS; Guo L; Sacristan C; Snyder NW; Blair IA; Milone MC; Dustin ML; Riley JL; Bernlohr DA; Murphy WJ; Fife BT; Munn DH; Miller JS; Serody JS; Freeman GJ; Sharpe AH; Turka LA; Blazar BR
J Clin Invest; 2016 Jul; 126(7):2642-60. PubMed ID: 27294527
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of PD1/PDL1 Expression and Their Clinicopathologic Association in EBV-associated Lymphoproliferative Disorders in Nonimmunosuppressed Patients.
Guo L; Bodo J; Durkin L; Hsi ED
Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):101-106. PubMed ID: 29084057
[TBL] [Abstract][Full Text] [Related]
7. Targeting of interleukin (IL)-17A inhibits PDL1 expression in tumor cells and induces anticancer immunity in an estrogen receptor-negative murine model of breast cancer.
Ma YF; Chen C; Li D; Liu M; Lv ZW; Ji Y; Xu J
Oncotarget; 2017 Jan; 8(5):7614-7624. PubMed ID: 27935862
[TBL] [Abstract][Full Text] [Related]
8. Soluble CD80 restores T cell activation and overcomes tumor cell programmed death ligand 1-mediated immune suppression.
Haile ST; Dalal SP; Clements V; Tamada K; Ostrand-Rosenberg S
J Immunol; 2013 Sep; 191(5):2829-36. PubMed ID: 23918985
[TBL] [Abstract][Full Text] [Related]
9. PD1/PDL1 expression is associated with increased TIM3 expression and tumor-infiltrating T lymphocytes in fibroblastic tumors.
Chen H; Liu H; Ai J; Du X; Sun Y; Xiao S
Clin Transl Oncol; 2022 Mar; 24(3):586-596. PubMed ID: 34741725
[TBL] [Abstract][Full Text] [Related]
10. The crosstalk between H. pylori virulence factors and the PD1:PD-L1 immune checkpoint inhibitors in progression to gastric cancer.
Aydın EM; Demir TD; Seymen N; Said SS; Oktem-Okullu S; Tiftikci A; Cicek B; Tokat F; Tozun N; Ince U; Sezerman U; Sayi-Yazgan A
Immunol Lett; 2021 Nov; 239():1-11. PubMed ID: 34363898
[TBL] [Abstract][Full Text] [Related]
11. Prolonged PD1 Expression on Neonatal Vδ2 Lymphocytes Dampens Proinflammatory Responses: Role of Epigenetic Regulation.
Hsu H; Boudova S; Mvula G; Divala TH; Mungwira RG; Harman C; Laufer MK; Pauza CD; Cairo C
J Immunol; 2016 Sep; 197(5):1884-92. PubMed ID: 27474072
[TBL] [Abstract][Full Text] [Related]
12. PD-L1 Ameliorates Murine Acute Graft-Versus-Host Disease by Suppressing Effector But Not Regulatory T Cells Function.
Tang L; Ma S; Gong H; Wang J; Xu Y; Wu D; Sun A
Arch Immunol Ther Exp (Warsz); 2019 Jun; 67(3):179-187. PubMed ID: 30927016
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of PD‑L1 expression by resveratrol and piceatannol in breast and colorectal cancer cells occurs via HDAC3/p300‑mediated NF‑κB signaling.
Lucas J; Hsieh TC; Halicka HD; Darzynkiewicz Z; Wu JM
Int J Oncol; 2018 Oct; 53(4):1469-1480. PubMed ID: 30066852
[TBL] [Abstract][Full Text] [Related]
14. The Protective and Immunomodulatory Effects of Fucoidan Against 7,12-Dimethyl benz[a]anthracene-Induced Experimental Mammary Carcinogenesis Through the PD1/PDL1 Signaling Pathway in Rats.
Xue M; Liang H; Tang Q; Xue C; He X; Zhang L; Zhang Z; Liang Z; Bian K; Zhang L; Li Z
Nutr Cancer; 2017; 69(8):1234-1244. PubMed ID: 29043842
[TBL] [Abstract][Full Text] [Related]
15. The link between the PDL1 costimulatory pathway and Th17 in fetomaternal tolerance.
D'Addio F; Riella LV; Mfarrej BG; Chabtini L; Adams LT; Yeung M; Yagita H; Azuma M; Sayegh MH; Guleria I
J Immunol; 2011 Nov; 187(9):4530-41. PubMed ID: 21949023
[TBL] [Abstract][Full Text] [Related]
16. Programmed Cell Death Ligand (PD-L)-1 Contributes to the Regulation of CD4
de Freitas E Silva R; Gálvez RI; Pereira VRA; de Brito MEF; Choy SL; Lotter H; Bosurgi L; Jacobs T
Front Immunol; 2020; 11():574491. PubMed ID: 33193363
[TBL] [Abstract][Full Text] [Related]
17. Survival and Pulmonary Injury After Neonatal Sepsis: PD1/PDL1's Contributions to Mouse and Human Immunopathology.
Fallon EA; Chung CS; Heffernan DS; Chen Y; De Paepe ME; Ayala A
Front Immunol; 2021; 12():634529. PubMed ID: 33746973
[TBL] [Abstract][Full Text] [Related]
18. PD1 and PDL1 molecules control suppressor activity of regulatory T cells in chronic Chagas cardiomyopathy patients.
Damasio MPS; Rocha MOC; Sousa GR; Ferreira KS; Fares-Gusmão RCG; Medeiros NI; Araujo FF; Chaves AT; Dutra WO; Correa-Oliveira R; Gomes JAS
Hum Immunol; 2019 Jul; 80(7):517-522. PubMed ID: 30853363
[TBL] [Abstract][Full Text] [Related]
19. PDL1 shapes the classical Hodgkin lymphoma microenvironment without inducing T-cell exhaustion.
Taylor JG; Truelove E; Clear A; Calaminici M; Gribben JG
Haematologica; 2023 Apr; 108(4):1068-1082. PubMed ID: 35833296
[TBL] [Abstract][Full Text] [Related]
20. Macrocyclic Compounds from Ansamycin Antibiotic Class as Inhibitors of PD1-PDL1 Protein-Protein Interaction.
Patil SP; Yoon SC; Aradhya AG; Hofer J; Fink MA; Enley ES; Fisher JE; Herb MC; Klingos A; Proulx JT; Fedorky MT
Chem Pharm Bull (Tokyo); 2018; 66(8):773-778. PubMed ID: 30068796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
